ResearchMoz

Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes

GBI Research
Published Date » 2012-12-14
No. Of Pages » 49
     
  Mobile Health (mHealth) Enhancing Healthcare and Improving Clinical Outcomes  
     
  Summary  
   
 GBI Research, the leading business intelligence provider, has released its latest research report: Mobile Health (mHealth) Enhancing Healthcare and Improving Clinical Outcomes. The report examines how mHealth, which is the facilitation of health-related information through mobile-enabled technologies, has been applied by the pharmaceutical industry in drug development and by healthcare providers in the developed and emerging economies to improve healthcare services and treatment outcomes. 
   
 It looks in detail at the ways in which the pharmaceutical industry has utilized mobile technologies in patient recruitment, compliance and retention of clinical trials, its role...
Table of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 6

2 Introduction 7
2.1 What is mHealth? 7
2.2 mHealth Aims 8
2.3 Stakeholder Groups Involved in the Funding and Provision of mHealth 9
2.4 Role of mHealth Technologies in the Pharmaceutical Industry 10
2.5 Key Market Segments in the mHealth Space 10
2.5.1 Mobile Health - Mobile Network Operators 10
2.5.2 Mobile Health - Pharmaceutical Industry 10
2.5.3 Mobile Health - Healthcare Professionals 11
2.5.4 Mobile Health - Healthcare Providers 11
2.5.5 Mobile Health - Consumers 11

3 mHealth in Drug Development 12
3.1 Introduction 12
3.2 Mobile Health in Pharmaceutical R&D 13
3.3 Patient Recruitment in Clinical Trials 14
3.3.1 Case Study: REMOTE (Pfizer) 14
3.3.2 Social Media 14
3.4 Patient Compliance and Retention in Clinical Trials 16
3.5 Safety Data Collection 17
3.6 Consumer Education 18
3.7 Mobile Medical Education 18
3.8 Drug Authentication 19
3.9 Post-market Surveillance 20

4 mHealth in Healthcare 21
4.1 Introduction 21
4.2 Electronic Personal Health Records 21
4.3 Electronic Health Records and Medical Records 22
4.3.1 Electronic Health Records and Observational Studies 22
4.4 Clinical Decision Support Systems 23
4.4.1 Case Study: Epocrates 23
4.5 Mobile Healthcare for Healthcare Providers 24
4.5.1 Prescribable Apps 25
4.5.2 Virtual Consultations 25
4.6 Recent Innovations in Medical Diagnostics 26
4.7 Barriers to mHealth Implementation 27

5 Transforming Healthcare in the Emerging Economies through mHealth 28
5.1 Introduction 28
5.2 Shortage of Medical Resources 29
5.3 Improving the Flow of Health Information 30
5.4 Role of the mHealth Alliance 31
5.5 mHealth Applications in the Emerging Economies 32
5.6 Disease Surveillance 33
5.7 Education and Awareness 35
5.7.1 Mobile Technology for Community Health 35
5.7.2 iTEACH 35
5.8 Healthcare Information Management Systems 37
5.9 Health Financing 38
5.10 Patient Monitoring and Support 38
5.11 Point-of-care Services 40
5.12 Barriers to mHealth Implementation in the Emerging Economies 42
5.13 Overall Conclusions 42

6 Appendix 43
6.1 Acronyms 43
6.2 Bibliography 44
6.3 Terminology 48
6.4 Methodology 48
6.4.1 Primary Research 48
6.4.2 Secondary Research 49
6.5 Contact Us 49
6.6 Disclaimer 49

List of Tables


Table 1: mHealth Disease Surveillance Programs 34
Table 2: mHealth Education and Awareness Programs 36
Table 3: mHealth Health Information Management Systems Programs 37
Table 4: mHealth Patient Monitoring and Support Programs 38
Table 5: mHealth Point-of-care Programs 41

List of Figures


Figure 1: mHealth Services 7
Figure 2: Key Stakeholders in the Provision of Funding to Drive mHealth Forward 9
Figure 3: Potential Application of mHealth by the Pharmaceutical Industry 13
Figure 4: Impact of Social Media on Phase III Recruitment of Diabetic Neuropathy Trial, 2011 15
Figure 5: Exco InTouch Services 16
Figure 6: PharmaSecure Drug Authentication Mobile App 19
Figure 7: Innovative Healthcare Software Platforms 20
Figure 8: Mobile Patient Communication Software 24
Figure 9: Patient Perception of how mHealth will Change Healthcare 28
Figure 10: Cell phone Subscriptions per 100 Inhabitants, 2001-2011 29
Figure 11: mHealth Applications in the Emerging Economies 30
Figure 12: mHealth Initiatives in Member States, by WHO region, 2011 32

Upcoming Reports:

Poland: skimmed milk market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the skimmed milk market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the skimmed milk market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the...
Dolomite Mining Market - Global Industry Analysis, Market Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
With the rapid increase in the construction and mining activities for dolomite, the market for dolomite mining and equipments has the potential to exhibit significant growth in the future. According to Mineral planning factsheet, out of a total of 12.2 Million tons of Dolomite mined in the United Kingdom, around 10.8 Million tons is used in the construction industry. Nearly 50 % of world’s carbonate reserves are in dolomite and these dolomite reserves can also host a significant amount of hydrocarbons. Hence with an abundance of reserves, diverse applications and easy mining...
Adjuvants Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
Adjuvant oncology treatment comprises of a class of cancer therapeutics which is followed after primary cancer treatment, to minimize the risk of reoccurrence of cancer. The major forms of adjuvant therapy are radiation therapy, chemotherapy, hormone therapy, biological therapy, and targeted therapy. Before deciding the adjuvant therapy to be used, statistical evidence is used by oncologists for the assessment of risk of disease relapse. Increase in prevalence of cancer, growing reimbursement initiatives by governments and insurance companies covering treatment for cancer and...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Pepsi Limon, A Brand New Addition to the Pepsi Portfolio
May 22, 2015  
To add a new dose of excitement to its cola offering, Pepsi has come up with the all new Pepsi Limon. This is a new flavored cola, which according to the company is manufactured with just the appropriate amount of real lime juice. The idea for the drink was inspired from the escalating preference of the Hispanic consumers. To satisfy the taste urges of the consumers, the new Pepsi Limon will...
Chinese Everbright Healthcare Fund to Acquire U.S. Firm Ambrx
May 22, 2015  
A group led by Chinese healthcare fund Everbright has chalked out details to buy U.S. based biotechnology firm Ambrx for an amount which in undisclosed. The deal, recently announces, is inclusive of other healthcare companies in mainland which are WuXi Pharma Tech and Shanghai Fosun Pharmaceutical, and investment company HOPU Investments.  The deal, which requires...
India’s Auto Exports Register Record High Figures in 2014-15
May 21, 2015  
In the fiscal year 2014-15, Indian factories exported a record number of 3.5 million vehicles, which is 15% higher than what they managed a year back. However, domestic sales rose by only 5% since last financial year, with 2.6 million units being sold.  Exports of utility vehicles, commercial vehicles, cars and two- wheelers have increased every year since 2000. But domestic car...
Turkey’s Labor Dispute Affects Ford’s Production
May 21, 2015  
With the ongoing labor dispute in Turkey, Ford’s Turkish manufacturing facility has been hit. Ford Otosan, a joint venture between the company and Turkey’s Koc Holding, mentioned that due to supply problems, production has been temporary stalled at its plants located at Yenikoy and Golcuk in northwestern part of the country. Earlier this week, production at Tofas and Oyak Renault,...
International Automakers Slashing Prices in China
May 21, 2015  
With a slowing Chinese economy, the international automakers are cutting prices of vehicles to be sold in the nation. This has hit the profit margins of the automakers who are struggling with a slowdown in demand.  Last week saw Ford Motor Co. and General Motors slashing their prices on Chinese models. It closely follows rival Volkswagen AG’s move last month to offer...